Cargando…

Delayed Perforation of the Right Ventricular Wall by a Single Standard-Caliber Implantable Cardioverter-Defibrillator Lead Detected by Multidetector Computed Tomography

We present an unusual case of a delayed right ventricular perforation by a single standard-caliber implantable cardioverter-defibrillator lead, which manifested 14 days after implantation. Multidetector computed tomography could clearly display the lead perforation, and allow for identification of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimori, An, Kobori, Atsushi, Michihiro, Nasu, Furukawa, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242028/ https://www.ncbi.nlm.nih.gov/pubmed/22194768 http://dx.doi.org/10.4070/kcj.2011.41.11.689

Ejemplares similares

Delayed right ventricular perforation complicated by intracardiac thrombosis after implantable cardioverter‐defibrillator implantation
por: Ito, Tsuyoshi, et al.
Publicado: (2017)

Right Ventricular and Chest Wall Perforation with Implantable Cardioverter-Defibrillator Lead with Lodgment into the Cutaneous Tissue of the Chest Wall
por: Carson, Philip S., et al.
Publicado: (2017)

Defibrillator lead migration and delayed presentation of right ventricular perforation
por: Kluis, Austin, et al.
Publicado: (2022)

Delayed perforation of the right ventricle by cardioverter-defibrillator lead – safe transvenous lead extraction by mechanical systems
por: Ząbek, Andrzej, et al.
Publicado: (2023)

Identification and management of right ventricular perforation using pacemaker and cardioverter-defibrillator leads: A case series and mini review
por: Akbarzadeh, Mohammad Ali, et al.
Publicado: (2017)

Delayed right ventricular defibrillation lead perforation presenting as cardiac tamponade and treated surgically
por: Noguchi, Masahiko, et al.
Publicado: (2017)

Delayed presentation of right ventricular lead perforation following defibrillator implantation: a case report
por: Ahlert, Daniel, et al.
Publicado: (2019)

Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients
por: Al-Ghamdi, Bandar, et al.
Publicado: (2018)

Delayed cardiac perforation of the Durata implantable cardioverter-defibrillator lead more than 1 year after implantation
por: Sharma, Sandeep K., et al.
Publicado: (2016)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction
por: Jimenez-Juan, Laura, et al.
Publicado: (2017)

Significance of intraoperative testing in right-sided implantable cardioverter-defibrillators
por: Keyser, Andreas, et al.
Publicado: (2013)

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
por: Orgeron, Gabriela M., et al.
Publicado: (2018)

Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2020)

Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy
por: Bosman, Laurens P, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications
por: Orgeron, Gabriela M., et al.
Publicado: (2017)

Embodying a New Meaning of Being At Risk: Living With an Implantable Cardioverter Defibrillator for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Manuel, April, et al.
Publicado: (2016)

Anesthetic management in a patient with arrhythmogenic right ventricular cardiomyopathy and an implantable cardioverter defibrillator: a case report
por: Ohyama, Yoko, et al.
Publicado: (2020)

Performance of an automated external cardioverter defibrillator for inhospital ventricular malignant arrhythmia
por: Timerman, S, et al.
Publicado: (2003)

Epicardial Cardioverter Defibrillator Implantation due to Post-Fontan Ventricular Tachycardia
por: Papakonstantinou, Nikolaos A, et al.
Publicado: (2020)

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator
por: Okada, Kozo, et al.
Publicado: (2020)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy
por: Tsukahara, Keita, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Recurrent implantable cardioverter-defibrillator shocks due to automatic deactivation of a right ventricular lead noise discrimination algorithm
por: Seiler, Thomas, et al.
Publicado: (2022)

Very late perforation by a Riata implantable cardioverter‐defibrillator lead—A case report
por: Nozoe, Masatsugu, et al.
Publicado: (2018)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
por: An, Yoshimori, et al.
Publicado: (2017)

Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device
por: Zormpas, Christos, et al.
Publicado: (2020)

Electrical injury‐induced ventricular fibrillation documented and treated with an implantable cardioverter defibrillator
por: Higami, Shigeo, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Usefulness of lead repositioning to improve subcutaneous electrocardiogram sensing in patients with arrhythmogenic right ventricular cardiomyopathy with subcutaneous implantable cardioverter-defibrillator
por: Sasaki, Shingo, et al.
Publicado: (2020)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_c7eo2n85sduegg1nkki0gomcqv